Evaluates solriamfetol's impact on neuropsychological outcomes in obstructive sleep apnea, implying potential benefits for treatment.
To evaluate the effect of solriamfetol treatment on neuropsychological outcomes in patients with excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) in the real-world SURWEY study.
No takes yet. Share an insight, caveat, or question.
Winter et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: